A conceptual framework for clinical trials in SLE and other multisystem diseases.
about
Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?Methotrexate in systemic lupus erythematosus.
P2860
A conceptual framework for clinical trials in SLE and other multisystem diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@ast
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@en
type
label
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@ast
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@en
prefLabel
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@ast
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@en
P2093
P2860
P1433
P1476
A conceptual framework for clinical trials in SLE and other multisystem diseases.
@en
P2093
J M Esdaile
M Corzillius
P2860
P304
P356
10.1191/096120399680411290
P577
1999-01-01T00:00:00Z